← Back to Search

AGPM for Spanish Speakers for Acute Lymphoblastic Leukemia

N/A
Recruiting
Led By Andrew A Dwyer, PhD
Research Sponsored by Boston College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Able to provide opt-in electronic informed consent
Adult (18+ yrs.)
Must not have
Under age 18 yrs.
Not able to provide opt-in electronic informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to two weeks
Awards & highlights

Summary

"This trial aims to test a questionnaire about attitudes towards genomics and precision medicine in both English and Spanish. The goal is to validate the Spanish version of the questionnaire among Hispanic, Latino/a, or Latin

Who is the study for?
This trial is for individuals identifying as Hispanic, Latino/a, or Latinx who have been diagnosed with Acute Lymphoblastic Leukemia. The study aims to include participants to validate a Spanish version of an attitudes survey on genomics and precision medicine.Check my eligibility
What is being tested?
The trial is testing the reliability of two versions of a survey called 'Attitudes Toward Genomics and Precision Medicine' (AGPM), one in English and another in Spanish, among people from specific ethnic backgrounds.See study design
What are the potential side effects?
Since this trial involves completing surveys rather than medical treatments, there are no direct physical side effects associated with participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can give my consent electronically.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.
Select...
I cannot give electronic consent.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to two weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to two weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Psychometric properties
Secondary outcome measures
Health literacy/numeracy

Trial Design

2Treatment groups
Experimental Treatment
Group I: AGPM for Spanish SpeakersExperimental Treatment1 Intervention
Participants identifying as Hispanic, Latino/a, or Latinx whose primary language is Spanish
Group II: AGPM for English SpeakersExperimental Treatment1 Intervention
Participants identifying as Hispanic, Latino/a, or Latinx whose primary language is English

Find a Location

Who is running the clinical trial?

Boston CollegeLead Sponsor
39 Previous Clinical Trials
48,107 Total Patients Enrolled
Andrew A Dwyer, PhDPrincipal InvestigatorBoston College
2 Previous Clinical Trials
1,239 Total Patients Enrolled
~667 spots leftby Jul 2025